Company
Edgewise
Dedicated to transforming cardiovascular disease
Also known as Edgewise Therapeutics, Edgewise Therapeutics, Inc.
- Status
- Operatingas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- Boulder, Colorado, United States
- Legal name
- Edgewise Therapeutics, Inc.
- edgewisetx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
At Edgewise, we’re bringing our unique expertise to develop novel therapeutics for serious cardiovascular diseases – with determination, integrity and a strong commitment to patients.
Funding snapshot
- Total raised
- $120MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $95M2020-12-03
Funding rounds
- Round, 2020
- $95M2020-12-03, SEC form D sold, 21 investors
- Round, 2019
- $25.1M2019-08-27, SEC form D sold, 6 investors
About the company
- Status notes
- Acquired by Qualcomm (2022)
Exit
- Acquisition
- 2022
Loading relationship preview